Jazz Pharmaceuticals To Showcase New Real-World Evidence Reinforcing Epidiolex® (Cannabidiol) Benefits And Broad-Spectrum Efficacy In Treatment-Resistant Epilepsies At The American Epilepsy Society 2024 Annual Meeting
Jazz Pharmaceuticals To Showcase New Real-World Evidence Reinforcing Epidiolex® (Cannabidiol) Benefits And Broad-Spectrum Efficacy In Treatment-Resistant Epilepsies At The American Epilepsy Society 2024 Annual Meeting . (MENAFN - PR Newswire) 
  
  
 
 
 
 
 
 Data from nine abstracts to be presented, including first data from the EpiCom Trial, a prospective evaluation of behavioral outcomes in patients with ...
América - MenaFN
Jordania
https://menafn.com/images/Menafn_SmallLogo.jpg
https://menafn.com/1108965748/Jazz-Pharmaceuticals-To-Showcase-New-Real-World-Evidence-Reinforcing-Epidiolex-Cannabidiol-Benefits-And-Broad-Spectrum-Efficacy-In-Treatment-Resistant-Epilepsies-At-The-American-Epilepsy-Society-2024-Annual-Meeting
2024-12-06
rss
(MENAFN - PR Newswire) 
  
  
 
 
 
 
 
 Data from nine abstracts to be presented, including first data from the EpiCom Trial, a prospective evaluation of behavioral outcomes in patients with ...
Jazz Pharmaceuticals To Showcase New Real-World Evidence Reinforcing Epidiolex® (Cannabidiol) Benefits And Broad-Spectrum Efficacy In Treatment-Resistant Epilepsies At The American Epilepsy Society 2024 Annual Meeting